Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of California at Los Angeles - UCLA
25
mi
from 91732
Los Angeles, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of California at Los Angeles - UCLA
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
VA Greater Los Angeles Healthcare System
25
mi
from 91732
Los Angeles, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
VA Greater Los Angeles Healthcare System
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Stanford Univ Med Ctr
328
mi
from 91732
Stanford, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Stanford Univ Med Ctr
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Colorado Cardiac and Vascular Center
825
mi
from 91732
Aurora, CO
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Colorado Cardiac and Vascular Center
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Cleveland Clinic Florida
2303
mi
from 91732
Weston, FL
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Cleveland Clinic Florida
2303
mi
from 91732
Weston, FL
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
The Emory Clinic
1922
mi
from 91732
Atlanta, GA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
The Emory Clinic
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Chicago
1730
mi
from 91732
Chicago, IL
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Chicago
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Kansas Medical Center
1332
mi
from 91732
Kansas City, KA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Lsu Health Sciences Center
1655
mi
from 91732
New Orleans, LA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Lsu Health Sciences Center
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Maryland Medical Center Division of Cardiology
2301
mi
from 91732
Baltimore, MD
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Maryland Medical Center Division of Cardiology
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Boston University Medical Center
2578
mi
from 91732
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Boston University Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Tufts Medical Center
2578
mi
from 91732
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Tufts Medical Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Michigan
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Abbott Northwestern Hospital
1510
mi
from 91732
Minneapolis, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Abbott Northwestern Hospital
1510
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Mary M Parkes Center
2245
mi
from 91732
Rochester, NY
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Mary M Parkes Center
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Cleveland Clinic Foundation
2033
mi
from 91732
Cleveland, OH
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Cleveland Clinic Foundation
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Ohio State University Martha Morehouse Medical Pavilion
1960
mi
from 91732
Columbus, OH
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Ohio State University Martha Morehouse Medical Pavilion
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Allegheny General Hospital
2118
mi
from 91732
Pittsburgh, PA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Allegheny General Hospital
2118
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of Pittsburgh
2121
mi
from 91732
Pittsburgh, PA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Pittsburgh
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
U.T. Southwestern Medical Center
1225
mi
from 91732
Dallas, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
U.T. Southwestern Medical Center
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Baylor College of Medicine
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Scott & White Memorial Hospital
1211
mi
from 91732
Temple, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Scott & White Memorial Hospital
1211
mi
from 91732
Temple, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Inova Heart and Vascular Institute
2273
mi
from 91732
Falls Church, VA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Inova Heart and Vascular Institute
2273
mi
from 91732
Falls Church, VA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Aurora St. Luke's Medical Center
1726
mi
from 91732
Milwaukee, WI
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Aurora St. Luke's Medical Center
1726
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of California at San Francisco
356
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
Alberta Health Services
1189
mi
from 91732
Calgary,
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Alberta Health Services
1189
mi
from 91732
Calgary,
Click here to add this to my saved trials
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated:  10/20/2015
Sinai Hospital of Baltimore
2298
mi
from 91732
Baltimore, MD
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated: 10/20/2015
Sinai Hospital of Baltimore
2298
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Medication Adherence With Polyglot Meducation
Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology
Status: Enrolling
Updated:  10/22/2015
Durham VA Medical Center
2198
mi
from 91732
Durham, NC
Medication Adherence With Polyglot Meducation
Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology
Status: Enrolling
Updated: 10/22/2015
Durham VA Medical Center
2198
mi
from 91732
Durham, NC
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Arizona Heart Rhythm Research Center
344
mi
from 91732
Phoenix, AZ
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Arizona Heart Rhythm Research Center
344
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
University of Southern California
11
mi
from 91732
Los Angeles, CA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
University of Southern California
11
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
George Washington University
2281
mi
from 91732
Washington,
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
George Washington University
2281
mi
from 91732
Washington,
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Florida Hospital and Cardiovascular Institute
2184
mi
from 91732
Orlando, FL
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Florida Hospital and Cardiovascular Institute
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Florida Cardiovascular Institute
2135
mi
from 91732
Tampa, FL
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Florida Cardiovascular Institute
2135
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Cardiovascular Institute of the South
1626
mi
from 91732
Houma, LA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Cardiovascular Institute of the South
1626
mi
from 91732
Houma, LA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Cardiac and Vascular Research Center of Northern Michigan
1908
mi
from 91732
Petosky, MI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Cardiac and Vascular Research Center of Northern Michigan
1908
mi
from 91732
Petosky, MI
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Michigan Cardiovascular Institute
1931
mi
from 91732
Saginaw, MI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Michigan Cardiovascular Institute
1931
mi
from 91732
Saginaw, MI
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
University Medical Center of Southern Nevada
215
mi
from 91732
Las Vegas, NV
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
University Medical Center of Southern Nevada
215
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Oklahoma Heart Hospital
1162
mi
from 91732
Oklahoma City, OK
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Oklahoma Heart Hospital
1162
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Allegheny General Hospital
2118
mi
from 91732
Pittsburgh, PA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Allegheny General Hospital
2118
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
Aspirus Wausau Hospital
1675
mi
from 91732
Wausau, WI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Aspirus Wausau Hospital
1675
mi
from 91732
Wausau, WI
Click here to add this to my saved trials
Combined Renin Inhibition/Beta-blockade
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status: Enrolling
Updated:  10/26/2015
The Rogosin Institute
2435
mi
from 91732
New York, NY
Combined Renin Inhibition/Beta-blockade
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status: Enrolling
Updated: 10/26/2015
The Rogosin Institute
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults
Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults
Status: Enrolling
Updated:  11/3/2015
Purdue University - Stone Hall 700 W State St
1755
mi
from 91732
W Lafayette, IN
Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults
Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults
Status: Enrolling
Updated: 11/3/2015
Purdue University - Stone Hall 700 W State St
1755
mi
from 91732
W Lafayette, IN
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
Yale Cancer Center
2486
mi
from 91732
New Haven, CT
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
Yale Cancer Center
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
University of Texas Health Science Center at Houston
1352
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
VA Medical Center West Haven
2484
mi
from 91732
West Haven, CT
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
VA Medical Center West Haven
2484
mi
from 91732
West Haven, CT
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
Brigham and Women's
2578
mi
from 91732
Boston, MA
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
Brigham and Women's
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials